{"meta":{"query_hash":"ebacd331f739","filters":{"venue":"touchREVIEWS in Oncology & Haematology"},"cohort_total":12,"direct_labels_cover":0,"predictions_cover":12,"exported":12,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ebacd331f739","api":"https://metacan.xera.ac/api/v1/cohort?venue=touchREVIEWS+in+Oncology+%26+Haematology"},"results":[{"id":"W2493321731","doi":"10.17925/ohr.2012.08.2.123","title":"Trauma-related Coagulopathy—Current Concepts","year":2012,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Coagulopathy; Medicine; Intensive care medicine; Consumptive Coagulopathy; Surgery","score_opus":0.059250287827643286,"score_gpt":0.42475013974147724,"score_spread":0.36549985191383394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493321731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010297183,0.9961718,0.00014290567,0.0019512327,0.0007283401,0.0000043915393,0.000008501158,0.000007330064,0.0008825823],"genre_scores_gemma":[0.0011857578,0.9950624,0.00026418286,0.0011529644,0.0019714674,0.000010595054,0.000017967928,0.0000015907584,0.00033309963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995029,0.00011592411,0.00009934397,0.00007258062,0.00017230424,0.00003697825],"domain_scores_gemma":[0.99782073,0.0011278964,0.0003284533,0.0000653925,0.00050482445,0.00015278618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001724564,0.0009973733,0.0012665186,0.0028239782,0.0005069214,0.002824185,0.0015895761,0.0021002085,0.004729749],"category_scores_gemma":[0.0023866075,0.00027693994,0.00061402377,0.0036291783,0.0016601637,0.0039226483,0.0010405713,0.0027202324,0.0019322737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017085834,0.00014181659,0.0008809377,0.028133953,0.00015827332,0.00094970525,0.00024798367,0.00040084895,0.001136579,0.012811237,0.082517415,0.8724504],"study_design_scores_gemma":[0.000036106456,0.00018415705,0.00208503,0.015504636,0.00023511807,0.0053423825,0.0004487549,0.00021184665,0.00044922158,0.022849254,0.9526149,0.00003847579],"about_ca_topic_score_codex":0.00085783284,"about_ca_topic_score_gemma":0.0008428732,"teacher_disagreement_score":0.004729749,"about_ca_system_score_codex":0.0014107549,"about_ca_system_score_gemma":0.0016251195,"threshold_uncertainty_score":0.01582259},"labels":[],"label_agreement":null},{"id":"W2495051483","doi":"10.17925/ohr.2014.10.2.110","title":"Systemic Treatment for Gastrointestinal Stromal Tumor—A State of Art","year":2014,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"GiST; Regorafenib; Sunitinib; Medicine; Imatinib; Stromal tumor; Tyrosine-kinase inhibitor; Imatinib mesylate; Oncology; Targeted therapy; Tyrosine kinase; Internal medicine; Adjuvant; Cancer research; Stromal cell; Cancer; Receptor; Colorectal cancer","score_opus":0.04687913405771255,"score_gpt":0.3725796975989255,"score_spread":0.32570056354121296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495051483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001977202,0.96878034,0.001071733,0.01975812,0.0021842525,0.000023491122,0.000041836574,0.00005280877,0.006110259],"genre_scores_gemma":[0.0160461,0.95723724,0.0019720527,0.0121863205,0.007487232,0.000043641827,0.00012613712,0.0000355308,0.0048657963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939346,0.0001918267,0.00005546776,0.00009138157,0.00020518992,0.000062684216],"domain_scores_gemma":[0.99843913,0.0007877713,0.00014867549,0.00011946149,0.00033390502,0.0001711404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017263991,0.0003191829,0.00068608054,0.00071676465,0.00047309426,0.0018375552,0.0006229853,0.0011553223,0.0059702727],"category_scores_gemma":[0.0016187724,0.00018543673,0.00057561405,0.000700652,0.0011368851,0.0022036552,0.00085934956,0.002923365,0.002309405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013156464,0.00011464169,0.0005647321,0.0017881317,0.00006860973,0.00021343034,0.00008801937,0.0002610279,0.0021058554,0.0068853535,0.0523581,0.9354205],"study_design_scores_gemma":[0.00005519613,0.000384111,0.0015713378,0.001600374,0.00006690099,0.0013385232,0.000112772366,0.00028908104,0.0012421944,0.005111921,0.9882067,0.00002085359],"about_ca_topic_score_codex":0.0005320756,"about_ca_topic_score_gemma":0.001400471,"teacher_disagreement_score":0.0059702727,"about_ca_system_score_codex":0.0008570897,"about_ca_system_score_gemma":0.00080759136,"threshold_uncertainty_score":0.019972563},"labels":[],"label_agreement":null},{"id":"W2498090476","doi":"10.17925/ohr.2015.11.01.19","title":"A Systematic Review of Factors Influencing Older Adults’ Hypothetical Treatment Decisions","year":2015,"lang":"en","type":"review","venue":"touchREVIEWS in Oncology & Haematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Council of University Libraries; Université de Montréal; Princess Margaret Cancer Centre; McGill University; Children's Hospital of Eastern Ontario; Jewish General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer treatment; Willingness to accept; Older people; Systematic review; Cancer; Gerontology; Willingness to pay; Demography; MEDLINE; Internal medicine","score_opus":0.27017614399736867,"score_gpt":0.5190729546122294,"score_spread":0.2488968106148607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498090476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013228836,0.9968777,0.0002000109,0.00026982668,0.000082105136,0.00034662313,0.0005390344,0.0000071264712,0.00035466],"genre_scores_gemma":[0.0176497,0.9799024,0.00081725715,0.00048808102,0.00004905002,0.00059291406,0.00037246544,0.000004638609,0.00012352302],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98899907,0.005135676,0.0036517363,0.0005923287,0.0014380732,0.00018308542],"domain_scores_gemma":[0.940626,0.04836704,0.0078080334,0.00045887823,0.0024268036,0.00031322843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011181089,0.001378312,0.0055551906,0.0071062194,0.00060691184,0.0023428793,0.0015758212,0.0014461034,0.004824055],"category_scores_gemma":[0.066553466,0.00089378114,0.008146229,0.007773762,0.0007118159,0.0018644106,0.0012205831,0.0012574681,0.00034496054],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017283567,0.000012633652,0.00097169937,0.94946074,0.010747005,0.00009136665,0.00024428515,0.00013179843,0.00006661541,0.00022650739,0.0014384476,0.036436126],"study_design_scores_gemma":[0.00022267658,0.00015061794,0.004945437,0.9062776,0.065953076,0.00036781063,0.00036374744,0.00008925008,0.00012867809,0.0004032125,0.021058222,0.00003964602],"about_ca_topic_score_codex":0.010426768,"about_ca_topic_score_gemma":0.031218367,"teacher_disagreement_score":0.011181089,"about_ca_system_score_codex":0.0035569107,"about_ca_system_score_gemma":0.009538393,"threshold_uncertainty_score":0.05913192},"labels":[],"label_agreement":null},{"id":"W2504029159","doi":"10.17925/ohr.2010.06.0.42","title":"Pre-operative Targeted Therapies in Patients with Hepatic Colorectal Cancer Metastases—Bevacizumab versus Cetuximab","year":2010,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Cetuximab; Bevacizumab; Colorectal cancer; Oncology; Chemotherapy; Internal medicine; Disease; Systemic therapy; Cancer; Surgery","score_opus":0.01792331745637213,"score_gpt":0.347404386023866,"score_spread":0.3294810685674938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504029159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4802285,0.5018918,0.0006819851,0.006460139,0.0006065779,0.000084382904,0.00006743078,0.00002151845,0.009957644],"genre_scores_gemma":[0.8886154,0.10607702,0.0008350969,0.0018877458,0.0010063086,0.000052244526,0.000112194226,0.000004333027,0.0014095614],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999821,0.00009708124,0.000018677429,0.000013695643,0.00002821044,0.000021309594],"domain_scores_gemma":[0.9994531,0.0003332695,0.00010036872,0.000015381696,0.000021285121,0.00007662866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004979854,0.00009610333,0.0005798369,0.00019162086,0.00010758844,0.0003025534,0.00017960879,0.00034598156,0.0013091255],"category_scores_gemma":[0.0012165467,0.000057343233,0.0002500303,0.00019727436,0.00017599812,0.0002574594,0.0001286521,0.00059560256,0.00019205785],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028277468,0.001447089,0.037735734,0.0017505689,0.0006821309,0.0005949309,0.00017347714,0.00051793223,0.008778893,0.00084331,0.0044127074,0.91478574],"study_design_scores_gemma":[0.010239431,0.1356215,0.66368544,0.003530347,0.0039791907,0.01425612,0.0009715845,0.0020028653,0.023239143,0.0032866213,0.13904133,0.0001463362],"about_ca_topic_score_codex":0.00041059853,"about_ca_topic_score_gemma":0.0021520006,"teacher_disagreement_score":0.0013091255,"about_ca_system_score_codex":0.00028154431,"about_ca_system_score_gemma":0.00026595272,"threshold_uncertainty_score":0.0043794513},"labels":[],"label_agreement":null},{"id":"W2617733729","doi":"10.17925/ohr.2017.13.01.41","title":"Paraneoplastic Syndromes in Children with Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Malignancy; Limbic encephalitis; Lymphoma; Hodgkin lymphoma; Pathophysiology; Pathology; Antibody; Immunology; Autoantibody","score_opus":0.03430934729151551,"score_gpt":0.3440599411965141,"score_spread":0.3097505939049986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617733729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20189686,0.71982944,0.0014688824,0.0071619744,0.00091012474,0.00007940461,0.0002640886,0.00023260762,0.06815661],"genre_scores_gemma":[0.6785715,0.30660507,0.0018176744,0.0040716305,0.0013135037,0.00005896818,0.0002699738,0.000027702426,0.0072639645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998462,0.000034924567,0.000016108605,0.00001789472,0.00004132499,0.00004354636],"domain_scores_gemma":[0.9997484,0.00009286651,0.00007645689,0.0000065452477,0.000026121757,0.00004958665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019272634,0.00026886168,0.00042297516,0.0005018031,0.00032948266,0.0004408016,0.00015995554,0.0006108822,0.003207576],"category_scores_gemma":[0.0007500698,0.00014112497,0.00017809936,0.00042776763,0.00044457358,0.0004283091,0.0004775071,0.00080128224,0.00060533907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002928269,0.00017747862,0.22588928,0.0034644974,0.00015716358,0.23409475,0.0025698666,0.00046686738,0.006855324,0.008200978,0.05908664,0.45874432],"study_design_scores_gemma":[0.000050639366,0.0001939072,0.14118622,0.0022660939,0.0000912133,0.6542438,0.0011893491,0.00012607293,0.0013148834,0.0021049052,0.19720869,0.000024232586],"about_ca_topic_score_codex":0.0010360957,"about_ca_topic_score_gemma":0.0016906832,"teacher_disagreement_score":0.003207576,"about_ca_system_score_codex":0.00039738638,"about_ca_system_score_gemma":0.00034299624,"threshold_uncertainty_score":0.010730386},"labels":[],"label_agreement":null},{"id":"W2619722962","doi":"10.17925/ohr.2017.13.01.19","title":"Raising the Bar in Advanced Pancreatic Cancer","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Oxaliplatin; Irinotecan; Pancreatic cancer; Oncology; Internal medicine; Randomized controlled trial; Clinical trial; First line; Cancer; Colorectal cancer","score_opus":0.11714557525357153,"score_gpt":0.47556778613374595,"score_spread":0.35842221088017445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619722962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001171602,0.7520903,0.0007040887,0.22346768,0.017277608,0.000009065171,0.000053313783,0.000073119685,0.005153196],"genre_scores_gemma":[0.024201255,0.78761196,0.0012995229,0.11212475,0.06933386,0.000029071023,0.00011866165,0.00008119014,0.005199666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980597,0.00083779276,0.00017293886,0.00023561461,0.00047316853,0.00022067595],"domain_scores_gemma":[0.9905246,0.005298458,0.000564066,0.00046065156,0.0017284107,0.0014238292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005795728,0.00043858122,0.0012640902,0.001039264,0.0013046545,0.0040008407,0.0011828447,0.005232876,0.0074211378],"category_scores_gemma":[0.015343453,0.00028613737,0.00072546565,0.0010623519,0.003983893,0.006475102,0.0036374587,0.012557431,0.0032804564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030640856,0.00006699996,0.0013622055,0.0033788586,0.000093309696,0.0007084672,0.0004635581,0.00032121863,0.0008315349,0.025656741,0.40787986,0.5589308],"study_design_scores_gemma":[0.0000528385,0.0001398399,0.0012288244,0.0028306912,0.00005143382,0.0011567993,0.0006536296,0.00010547267,0.00028397806,0.02717395,0.9662882,0.0000343003],"about_ca_topic_score_codex":0.0012438833,"about_ca_topic_score_gemma":0.002486448,"teacher_disagreement_score":0.0074211378,"about_ca_system_score_codex":0.0018180478,"about_ca_system_score_gemma":0.0022477873,"threshold_uncertainty_score":0.030651152},"labels":[],"label_agreement":null},{"id":"W2770447500","doi":"10.17925/ohr.2017.13.02.117","title":"Adrenal Oligometastases Secondary to Non-small Cell Lung Cancer—What is the Optimal Treatment Approach?","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lung cancer; Adrenalectomy; Retrospective cohort study; Stage (stratigraphy); Chemotherapy; Radiation therapy; Radical surgery; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.042011681780820424,"score_gpt":0.36247305074150465,"score_spread":0.3204613689606842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770447500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004352198,0.9963437,0.000051293286,0.0025795451,0.00028041302,0.0000054871575,0.000022821856,0.000003090547,0.00027849578],"genre_scores_gemma":[0.006205785,0.9907828,0.0003308674,0.0013957918,0.0010594869,0.00001482955,0.00005479804,0.0000034851673,0.00015219153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879456,0.00045289428,0.00033264328,0.000121321806,0.00022731902,0.000071228016],"domain_scores_gemma":[0.9944101,0.003262271,0.0011441801,0.00009632996,0.0008919092,0.00019520224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034256736,0.00040080035,0.002022008,0.0025958885,0.00036622785,0.0024118288,0.0009466169,0.0013173273,0.002578747],"category_scores_gemma":[0.008119815,0.00023421753,0.0007907697,0.0023635263,0.00086626946,0.0024296897,0.0005617419,0.0010134575,0.0007805861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005000634,0.00009499438,0.0039810403,0.113219865,0.0011457881,0.0006184483,0.00026502582,0.00030910491,0.0015762793,0.0025253792,0.034315914,0.841448],"study_design_scores_gemma":[0.0002694747,0.00065236207,0.024459481,0.26129097,0.004587534,0.004875103,0.0031866143,0.00046170634,0.0013604499,0.01233013,0.6863979,0.00012830607],"about_ca_topic_score_codex":0.0013133505,"about_ca_topic_score_gemma":0.0024262907,"teacher_disagreement_score":0.0034256736,"about_ca_system_score_codex":0.0010880932,"about_ca_system_score_gemma":0.0027418258,"threshold_uncertainty_score":0.018116891},"labels":[],"label_agreement":null},{"id":"W2800764700","doi":"10.17925/ohr.2018.14.1.21","title":"Pediatric Anaplastic Large Cell Lymphoma—A Review","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Lymphoma; Pathology","score_opus":0.022440804423905357,"score_gpt":0.34836774670896703,"score_spread":0.3259269422850617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800764700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021705424,0.99782383,0.000053353346,0.00050857203,0.000839163,0.0000047005624,0.00003256129,0.000008352683,0.0005123179],"genre_scores_gemma":[0.0018453288,0.99436176,0.00019780522,0.0013399638,0.0017162702,0.00000981982,0.0000867276,0.0000033082476,0.000438948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971837,0.00003642614,0.0000877339,0.000054085987,0.0000733256,0.000030099825],"domain_scores_gemma":[0.99887604,0.00052558206,0.0002596353,0.000022470667,0.00018867519,0.00012752676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059754436,0.0007183279,0.0012756141,0.004165204,0.00026554684,0.0013491156,0.0007550184,0.0010541566,0.004451806],"category_scores_gemma":[0.0015825545,0.0003702323,0.0006272263,0.0034986609,0.0003836122,0.0023186689,0.00081991375,0.0012071966,0.0017117595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002210348,0.00008322016,0.0026986087,0.034319133,0.00039017585,0.0023664515,0.00015198976,0.0002649015,0.0015766266,0.0010857522,0.18405977,0.77278227],"study_design_scores_gemma":[0.000059173246,0.0001309004,0.0054864143,0.02399594,0.00071755046,0.014174201,0.0002619683,0.000083960214,0.00034185845,0.0006765164,0.9540308,0.000040752806],"about_ca_topic_score_codex":0.0010740295,"about_ca_topic_score_gemma":0.0025153786,"teacher_disagreement_score":0.004451806,"about_ca_system_score_codex":0.00060752186,"about_ca_system_score_gemma":0.0013034659,"threshold_uncertainty_score":0.014892817},"labels":[],"label_agreement":null},{"id":"W2998181651","doi":"10.17925/ohr.2019.15.2.78","title":"Understanding Survival Disparities in Gastric Cancer","year":2019,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cancer; Internal medicine","score_opus":0.1453113158276303,"score_gpt":0.38089018622657717,"score_spread":0.23557887039894687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998181651","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009011831,0.104332305,0.00072898786,0.82059026,0.019846098,0.000057834422,0.0063417004,0.00010010032,0.038990892],"genre_scores_gemma":[0.13917775,0.24150954,0.0028147688,0.5015515,0.08773499,0.0003530021,0.008265614,0.00018717466,0.018405646],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990132,0.00042519742,0.00006544706,0.000109627654,0.00023917585,0.00014732638],"domain_scores_gemma":[0.9879824,0.008469313,0.0006691372,0.00029144503,0.0014804328,0.0011072723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024541833,0.00022502786,0.00041243213,0.001165691,0.0006882452,0.002115012,0.00089457596,0.002222121,0.033489503],"category_scores_gemma":[0.020390764,0.00014199587,0.0007063023,0.0016010549,0.0006378213,0.0023905777,0.0013209934,0.0029538288,0.003207393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044147877,0.000042790245,0.013150793,0.0006838175,0.000121326404,0.00007205991,0.00033899944,0.00006665839,0.000054184617,0.005038354,0.8437468,0.13664013],"study_design_scores_gemma":[0.00012331846,0.00011810358,0.089922816,0.0122272065,0.00038970372,0.00044633285,0.0038130335,0.00037068131,0.00020290054,0.045351956,0.84697455,0.00005933067],"about_ca_topic_score_codex":0.014849551,"about_ca_topic_score_gemma":0.037309095,"teacher_disagreement_score":0.033489503,"about_ca_system_score_codex":0.0012891012,"about_ca_system_score_gemma":0.0035505956,"threshold_uncertainty_score":0.112033546},"labels":[],"label_agreement":null},{"id":"W3132286526","doi":"10.17925/ohr.2021.16.2.100","title":"<i>MET</i> Exon 14 Skipping Alterations in Non-small Cell Lung Carcinoma—Current Understanding and Therapeutic Advances","year":2021,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Liver physiology and pathology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Current (fluid); Medicine; Lung; Cancer research; Computational biology; Oncology; Internal medicine; Biology; Engineering","score_opus":0.06749003951685331,"score_gpt":0.35215664515223793,"score_spread":0.2846666056353846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132286526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07641041,0.8942022,0.0019295083,0.012816887,0.0013197609,0.00002784472,0.00042898042,0.00017181266,0.01269267],"genre_scores_gemma":[0.4313942,0.5499708,0.0032448273,0.0056576733,0.003512313,0.000043070686,0.00080053194,0.000050474355,0.0053261924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998323,0.000030358837,0.00001767146,0.000042962318,0.000048198035,0.000028594737],"domain_scores_gemma":[0.9997347,0.00011750937,0.00006926715,0.000010635518,0.000039104754,0.00002885486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004700728,0.00025942276,0.000535225,0.00044219484,0.00016316649,0.0009165682,0.00042778006,0.000692286,0.0014834689],"category_scores_gemma":[0.00056627655,0.000110709,0.00028993355,0.0006035048,0.00040736646,0.0003946501,0.00028240352,0.0007533187,0.0004905031],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096273026,0.000105257495,0.031934272,0.002137078,0.00021633408,0.004648076,0.00025133754,0.000980749,0.047036573,0.00506953,0.03314764,0.87351054],"study_design_scores_gemma":[0.00018848862,0.0014616707,0.22266093,0.0029512318,0.00097143947,0.05015307,0.0012531363,0.004510536,0.04577132,0.017368961,0.6525558,0.00015345981],"about_ca_topic_score_codex":0.00089093234,"about_ca_topic_score_gemma":0.0016219422,"teacher_disagreement_score":0.0014834689,"about_ca_system_score_codex":0.00046769882,"about_ca_system_score_gemma":0.00046810068,"threshold_uncertainty_score":0.0049626827},"labels":[],"label_agreement":null},{"id":"W4213090277","doi":"10.17925/ohr.2021.17.2.73","title":"Bruton's Tyrosine Kinase Inhibitors for the Treatment of Waldenström's Macroglobulinaemia: A Canadian Perspective","year":2021,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Canada; BeiGene","keywords":"Bruton's tyrosine kinase; Perspective (graphical); Waldenstrom macroglobulinemia; Medicine; Tyrosine kinase; Ibrutinib; Internal medicine; Computer science; Leukemia; Receptor; Lymphoma","score_opus":0.04450833492793894,"score_gpt":0.38975086359372274,"score_spread":0.3452425286657838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213090277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000415283,0.81050324,0.00016096044,0.16268091,0.014777099,0.000014516145,0.00011792434,0.000029104101,0.011301042],"genre_scores_gemma":[0.006098549,0.9184658,0.00042867364,0.050862033,0.016250588,0.000013327646,0.00008857563,0.00002145408,0.007770983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831593,0.0002491168,0.00012885254,0.00014413372,0.0008149978,0.00034702607],"domain_scores_gemma":[0.9927045,0.0015348898,0.0003931066,0.00007271956,0.0038076662,0.0014870734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004288597,0.0006880482,0.0012697763,0.0023406735,0.0019667177,0.0035493085,0.0015074837,0.0042795413,0.01102177],"category_scores_gemma":[0.0056338813,0.00026381193,0.0010076929,0.002612476,0.0030265383,0.0019724325,0.001045018,0.007436291,0.0017616316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036442617,0.00007487034,0.00042144858,0.0012565003,0.00008832169,0.00043144115,0.0001482642,0.0002849561,0.0007324513,0.01617685,0.7037431,0.27627736],"study_design_scores_gemma":[0.00012788604,0.00007215474,0.0010029625,0.0016417451,0.00007586079,0.00028982735,0.00012883254,0.000065121945,0.000104096725,0.001977303,0.99449146,0.00002274971],"about_ca_topic_score_codex":0.38074484,"about_ca_topic_score_gemma":0.6812815,"teacher_disagreement_score":0.6192552,"about_ca_system_score_codex":0.016620558,"about_ca_system_score_gemma":0.038078148,"threshold_uncertainty_score":0.7570573},"labels":[],"label_agreement":null},{"id":"W4247945137","doi":"10.17925/ohr.2015.11.01.74","title":"Gastrointestinal Stromal Tumors (GIST)—Paving the Way for Modern Oncology—Epidemiology, Diagnosis, Treatment","year":2015,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; GiST; Regorafenib; Sunitinib; Imatinib; Oncology; Internal medicine; Stromal tumor; Imatinib mesylate; Surgery; Radiology; Cancer; Stromal cell; Colorectal cancer","score_opus":0.24500849977105757,"score_gpt":0.46073877915552264,"score_spread":0.21573027938446507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247945137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028916544,0.96538824,0.0006957333,0.024709752,0.0018815629,0.0000117202235,0.000082540006,0.00003526859,0.004303531],"genre_scores_gemma":[0.017095316,0.9711702,0.0012362164,0.0036837242,0.0055196723,0.000011079939,0.00011731361,0.000010141725,0.0011562924],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995968,0.00012957743,0.000052659267,0.00005588842,0.00012546552,0.000039661147],"domain_scores_gemma":[0.9988857,0.0003501217,0.0002441513,0.000050229464,0.00029346868,0.00017634714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009689337,0.0002903136,0.00059638877,0.0014508347,0.00036326025,0.0013512393,0.0004295089,0.00094470906,0.0026536956],"category_scores_gemma":[0.0016983513,0.00015330577,0.00021303639,0.0018241353,0.0009881331,0.0020259551,0.0007655618,0.0019070058,0.0008485573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008570928,0.00007108132,0.009120066,0.0023735703,0.000060359824,0.00066979835,0.00015448254,0.00027845573,0.0016070998,0.013456505,0.08570343,0.8864194],"study_design_scores_gemma":[0.000017663773,0.00012534625,0.01797925,0.0030058902,0.00006470722,0.0064486284,0.00061209116,0.0002514754,0.0005628698,0.011732457,0.95916253,0.00003715937],"about_ca_topic_score_codex":0.0013120015,"about_ca_topic_score_gemma":0.0015017606,"teacher_disagreement_score":0.0026536956,"about_ca_system_score_codex":0.0010938758,"about_ca_system_score_gemma":0.0014773175,"threshold_uncertainty_score":0.008877456},"labels":[],"label_agreement":null}]}